T
321550
vs
K
KOSPI 200
Over the past 12 months, TiumBio Co Ltd has significantly outperformed KOSPI 200, delivering a return of +214% compared to the KOSPI 200's +105% growth.
Stocks Performance
321550 vs KOSPI 200
Performance Gap
321550 vs KOSPI 200
Performance By Year
321550 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
TiumBio Co Ltd
Glance View
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.